glp-1 vs Agonists for Weight Loss: A Side-by-Side Comparison GLP-1 medications for weight loss

Scientists are looking for better options

doi:10.4137/BMI.S11448 108. Saha, S., Chatterjee, M., Dutta, N., Sinha, S., & Mukhopadhyay, K

Providers should document pain levels, functional limitations, and objective findings like spasm or decreased range of motion

Molecular targeted therapy of glioblastoma

At the clinical level, renal biopsy samples from patients with DKD exhibit iron deposition, increased lipid peroxidation, and reduced GPX4 expression (Kim et al., 2021)

TNF- antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome